Speciality Medicines Limited (BOM:544738)

Speciality Medicines Statistics

Total Valuation

BOM:544738 has a market cap or net worth of INR 1.80 billion. The enterprise value is 1.85 billion.

Market Cap	1.80B
Enterprise Value	1.85B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BOM:544738 has 8.79 million shares outstanding.

Current Share Class	8.79M
Shares Outstanding	8.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	71.32%
Owned by Institutions (%)	n/a
Float	2.46M

Valuation Ratios

The trailing PE ratio is 18.37.

PE Ratio	18.37
Forward PE	n/a
PS Ratio	3.10
PB Ratio	5.89
P/TBV Ratio	5.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.21, with an EV/FCF ratio of -26.26.

EV / Earnings	25.68
EV / Sales	3.17
EV / EBITDA	20.21
EV / EBIT	20.64
EV / FCF	-26.26

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.16.

Current Ratio	5.50
Quick Ratio	1.69
Debt / Equity	0.16
Debt / EBITDA	0.55
Debt / FCF	-0.72
Interest Coverage	25.01

Financial Efficiency

Return on equity (ROE) is 30.43% and return on invested capital (ROIC) is 27.41%.

Return on Equity (ROE)	30.43%
Return on Assets (ROA)	17.67%
Return on Invested Capital (ROIC)	27.41%
Return on Capital Employed (ROCE)	26.81%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.84
Inventory Turnover	3.32

Taxes

In the past 12 months, BOM:544738 has paid 14.94 million in taxes.

Income Tax	14.94M
Effective Tax Rate	17.19%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	217,455

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544738 had revenue of INR 582.71 million and earned 71.96 million in profits. Earnings per share was 11.18.

Revenue	582.71M
Gross Profit	160.81M
Operating Income	89.55M
Pretax Income	86.90M
Net Income	71.96M
EBITDA	91.44M
EBIT	89.55M
Earnings Per Share (EPS)	11.18

Balance Sheet

The company has 8.46 million in cash and 50.47 million in debt, with a net cash position of -42.01 million or -4.78 per share.

Cash & Cash Equivalents	8.46M
Total Debt	50.47M
Net Cash	-42.01M
Net Cash Per Share	-4.78
Equity (Book Value)	306.22M
Book Value Per Share	47.58
Working Capital	298.03M

Cash Flow

In the last 12 months, operating cash flow was -64.32 million and capital expenditures -6.07 million, giving a free cash flow of -70.39 million.

Operating Cash Flow	-64.32M
Capital Expenditures	-6.07M
Depreciation & Amortization	1.89M
Net Borrowing	21.89M
Free Cash Flow	-70.39M
FCF Per Share	-8.01

Margins

Gross margin is 27.60%, with operating and profit margins of 15.37% and 12.35%.

Gross Margin	27.60%
Operating Margin	15.37%
Pretax Margin	14.91%
Profit Margin	12.35%
EBITDA Margin	15.69%
EBIT Margin	15.37%
FCF Margin	n/a

Dividends & Yields

BOM:544738 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.99%
FCF Yield	-3.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2